These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 26954800)

  • 1. Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients.
    Sankhla CS; Patil KB; Sawant N; Gupta S
    Neurol India; 2016; 64(2):239-45. PubMed ID: 26954800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?
    Nigro S; Morelli M; Arabia G; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A
    Parkinsonism Relat Disord; 2017 Aug; 41():31-36. PubMed ID: 28487107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
    Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
    Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
    Quattrone A; Nicoletti G; Messina D; Fera F; Condino F; Pugliese P; Lanza P; Barone P; Morgante L; Zappia M; Aguglia U; Gallo O
    Radiology; 2008 Jan; 246(1):214-21. PubMed ID: 17991785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's disease.
    Morelli M; Arabia G; Messina D; Vescio B; Salsone M; Chiriaco C; Perrotta P; Rocca F; Cascini GL; Barbagallo G; Nigro S; Quattrone A
    Mov Disord; 2014 Apr; 29(4):488-95. PubMed ID: 24573655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI measurements of brainstem structures in patients with vascular parkinsonism, progressive supranuclear palsy, and Parkinson's disease.
    Kim BC; Choi SM; Choi KH; Nam TS; Kim JT; Lee SH; Park MS; Yoon W
    Neurol Sci; 2017 Apr; 38(4):627-633. PubMed ID: 28078564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy.
    Hussl A; Mahlknecht P; Scherfler C; Esterhammer R; Schocke M; Poewe W; Seppi K
    Mov Disord; 2010 Oct; 25(14):2444-9. PubMed ID: 20878992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
    Eraslan C; Acarer A; Guneyli S; Akyuz E; Aydin E; Colakoglu Z; Kitis O; Calli MC
    Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of magnetic resonance planimetry and magnetic resonance parkinsonism index in discriminating Parkinson's disease and progressive supranuclear palsy: a retrospective study based on 1.5 and 3 T MRI.
    Nizamani WM; Mubarak F; Barakzai MD; Ahmed MS
    Int J Gen Med; 2017; 10():375-384. PubMed ID: 29184432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior cerebellar peduncle atrophy of progressive supranuclear palsy on phase difference enhanced imaging: a comparison with Parkinson's disease.
    Miyata M; Kakeda S; Yoneda T; Ide S; Okada K; Adachi H; Korogi Y
    Neuroradiology; 2023 Apr; 65(4):719-727. PubMed ID: 36670276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the Mesencephalon Indices to Differential Diagnosis of Parkinsonian Disorders.
    Oktay C; Özkaynak SS; Eseroğlu E; Karaali K
    Can Assoc Radiol J; 2020 Feb; 71(1):100-109. PubMed ID: 32062996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease.
    Morelli M; Arabia G; Salsone M; Novellino F; Giofrè L; Paletta R; Messina D; Nicoletti G; Condino F; Gallo O; Lanza P; Quattrone A
    Mov Disord; 2011 Feb; 26(3):527-33. PubMed ID: 21287599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease.
    Quattrone A; Bianco MG; Antonini A; Vaillancourt DE; Seppi K; Ceravolo R; Strafella AP; Tedeschi G; Tessitore A; Cilia R; Morelli M; Nigro S; Vescio B; Arcuri PP; De Micco R; Cirillo M; Weis L; Fiorenzato E; Biundo R; Burciu RG; Krismer F; McFarland NR; Mueller C; Gizewski ER; Cosottini M; Del Prete E; Mazzucchi S; Quattrone A
    Mov Disord; 2022 Jun; 37(6):1272-1281. PubMed ID: 35403258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
    Longoni G; Agosta F; Kostić VS; Stojković T; Pagani E; Stošić-Opinćal T; Filippi M
    Mov Disord; 2011 Feb; 26(2):247-55. PubMed ID: 21412831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic validity of magnetic resonance parkinsonism index in differentiating patients with progressive supranuclear palsy from patients with Parkinson's disease.
    Zhang K; Liang Z; Wang C; Zhang X; Yu B; Liu X
    Parkinsonism Relat Disord; 2019 Sep; 66():176-181. PubMed ID: 31420309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of optimal value of magnetic resonance planimetry and the parkinsonism index for the diagnosis of Parkinson's disease and progressive supranuclear palsy.
    Shetty N; Koteshwar P; Priyanka
    J Taibah Univ Med Sci; 2023 Dec; 18(6):1577-1585. PubMed ID: 37701844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple linear brainstem MRI measurements in the differential diagnosis of progressive supranuclear palsy from the parkinsonian variant of multiple system atrophy.
    Constantinides VC; Paraskevas GP; Stamboulis E; Kapaki E
    Neurol Sci; 2018 Feb; 39(2):359-364. PubMed ID: 29196955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy.
    Nigro S; Arabia G; Antonini A; Weis L; Marcante A; Tessitore A; Cirillo M; Tedeschi G; Zanigni S; Calandra-Buonaura G; Tonon C; Pezzoli G; Cilia R; Zappia M; Nicoletti A; Cicero CE; Tinazzi M; Tocco P; Cardobi N; Quattrone A
    Eur Radiol; 2017 Jun; 27(6):2665-2675. PubMed ID: 27761709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.